Clinical Trials
20 trialsT-DIS
Centre Oscar Lambret
TRABEPIO
Mario Negri Institute for Pharmacological Research
Trabectedin in Combination With Olaparib in Advanced Unresectable or Metastatic Sarcoma
University of Michigan Rogel Cancer Center
L-UteCIN
UNICANCER
TNT
Sarcoma Oncology Research Center, LLC
TAGGED
Sarcoma Oncology Research Center, LLC
NCT-PMO-1603
National Center for Tumor Diseases, Heidelberg
SYNERGIAS
Grupo Espanol de Investigacion en Sarcomas
HyperTET
Ludwig-Maximilians - University of Munich
NiTraSarc
University Medicine Greifswald
MITO 26
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
ATREUS
Mario Negri Institute for Pharmacological Research
Bevacizumab and Trabectedin +/- Carboplatin in Advanced Ovarian Cancer
Mario Negri Institute for Pharmacological Research
Immune Changes Following Trabectedin in Patients With Metastatic or Unresectable Sarcoma
Fred Hutchinson Cancer Center
TAUL
Mario Negri Institute for Pharmacological Research
Doxorubicin vs. Trabectedin Plus Doxorubicin in Non Operable and/or Metastatic STS
Grupo Espanol de Investigacion en Sarcomas
PACT-18
IRCCS San Raffaele
Ecteinascidin 743 in Treating Patients With Previously Treated Metastatic Osteosarcoma
Memorial Sloan Kettering Cancer Center
MITO15
Catholic University of the Sacred Heart
ET 743 (Yondelis) in Men With Advanced Prostate Cancer
Massachusetts General Hospital